← back to search

Thomas J. George

University of Florida Health · US
Area of research
Oncology · Cancer Research
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, and Colorectal Cancer Surgical Treatments.
h-index
55
citations
13,602
works
697
NIH funding
primary concept
Medicine
email

Recent publications

Somatic Genomic Profiling of Pancreatic Ductal Adenocarcinomas From a Diverse Cohort of Patients
Pancreas 2025cited by 9position: middledoi
A real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors
npj Precision Oncology 2025cited by 9position: middledoi
Utilizing Patient Input in Rectal Cancer Trial Design
JNCI Journal of the National Cancer Institute 2025cited by 3position: middledoi
Phase II results of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA) phase II/III study.
Journal of Clinical Oncology 2024cited by 36position: lastdoi
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
BMC Cancer 2024cited by 35position: middledoi
Identifying social determinants of health from clinical narratives: A study of performance, documentation ratio, and potential bias
Journal of Biomedical Informatics 2024cited by 28position: middledoi
SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer
Cancer 2024cited by 14position: middledoi
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms
JCO Precision Oncology 2024cited by 12position: firstdoi
Preoperative Treatment of Locally Advanced Rectal Cancer
New England Journal of Medicine 2023cited by 427position: middledoi
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
Journal of Clinical Oncology 2023cited by 132position: middledoi
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors
Cancer Immunology Immunotherapy 2023cited by 97position: middledoi
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials
Annals of Oncology 2023cited by 43position: middledoi
Sotorasib in <i>KRAS</i> p.G12C–Mutated Advanced Pancreatic Cancer
New England Journal of Medicine 2022cited by 454position: middledoi
First data for sotorasib in patients with pancreatic cancer with <i>KRAS</i> p.G12C mutation: A phase I/II study evaluating efficacy and safety
Journal of Clinical Oncology 2022cited by 43position: middledoi
Results of a phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response pathway deficient neoplasms.
Journal of Clinical Oncology 2022cited by 21position: firstdoi
Extracting social determinants of health from electronic health records using natural language processing: a systematic review
Journal of the American Medical Informatics Association 2021cited by 233position: middledoi
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
JAMA Oncology 2021cited by 187position: lastdoi
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database
JNCI Journal of the National Cancer Institute 2021cited by 43position: middledoi
The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer
Cancers 2021cited by 18position: middledoi
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
Nature Reviews Clinical Oncology 2020cited by 365position: middledoi
Clinical Trial Generalizability Assessment in the Big Data Era: A Review
Clinical and Translational Science 2020cited by 134position: middledoi
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database
JNCI Journal of the National Cancer Institute 2020cited by 84position: middledoi
Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
Cancer Medicine 2020cited by 20position: middledoi
Using Real-World Data to Rationalize Clinical Trials Eligibility Criteria Design: A Case Study of Alzheimer’s Disease Trials
medRxiv 2020cited by 14position: middledoi
The Florida Pancreas Collaborative Next-Generation Biobank: State-wide Infrastructure to Reduce Disparities and Improve Survival for a Racially and Ethnically Diverse Cohort of Patients with Pancreatic Cancer
medRxiv 2020cited by 0position: middledoi
Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline
Journal of Clinical Oncology 2019cited by 88position: middledoi
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors
Oncology 2019cited by 81position: middledoi
Racial and ethnic disparities in a state‐wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities
Cancer Medicine 2019cited by 39position: middledoi
Assessing the Validity of a <i>a priori</i> Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial Case Study.
PubMed 2019cited by 11position: middledoi
Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial Case Study
arXiv (Cornell University) 2019cited by 7position: middledoi

Grants

Atomic/Molecular Species Coupled to Solids and Rare Gas Clusters
NSF9196214$208,3101991–1994PIRePORTER
Atomic/Molecular Species Coupled to Solids and Rare Gas Clusters
NSF9016789$29,9901990–1991PIRePORTER
US-Japan Seminar on Theoretical Approaches to Energy Transfer and Photochemical Processes/Honolulu HI/December 1990
NSF9024389$01990–1991PIRePORTER
Laser-Induced Chemical Reactions and Energy Transfer
NSF8620274$245,0001987–1991PIRePORTER
Laser-Induced Bound-Continuum Interactions: Chemi-Ionization, Resonances and Bound States (Chemistry)
NSF8519053$102,0001985–1987PIRePORTER
Laser-Induced Bound-Continuum Interactions: Chemi- Ionization, Resonances and Bound States (Chemistry)
NSF8320185$116,0001984–1986PIRePORTER
Theoretical Studies of Laser-Induced Chemi-Ionization
NSF8022874$140,9221981–1984PIRePORTER
Travel to Attend: Faraday General Discussion: "Kinetics of State Selected Species"; Birmingham, England; April 9 - 11, 1979
NSF7819988$7071979–1979PIRePORTER
Laser-Assisted Chemistry and Ionic-Covalent Curve-Crossing Reactions
NSF7727826$112,0001978–1981PIRePORTER
Theoretical Aspects of Laser Radiation and Its Interaction With Atomic and Molecular Systems, Workshop at University OfRochester, June 2-5, 1977
NSF7714548$21,3401977–1978PIRePORTER
Travel to Attend: Meeting on Potential Energy Surfaces, Sussex, England, September 8 - 10, 1976
NSF7622478$7181976–1977PIRePORTER
Energy Transfer and Reaction Dynamics in Molecular Collisions
NSF7506775$76,0001975–1978PIRePORTER

Frequent collaborators

Jiang Bian · Regenstrief Institute9 papers (2016–2025)Yi Guo · Xi'an University of Science and Technology7 papers (2017–2025)Zhe He · South China Agricultural University6 papers (2016–2020)Greg Yothers · University of Pittsburgh6 papers (2018–2025)William R. Hogan · University of Florida5 papers (2019–2024)Jeffrey A. Meyerhardt · Harvard University4 papers (2019–2025)Leonard B. Saltz · Cornell University4 papers (2020–2023)Qian Shi · Tongji University4 papers (2020–2025)Norman Wolmark · NRG Oncology4 papers (2018–2024)Carmen J. Allegra · University of Florida Health4 papers (2018–2024)John H. Strickler · Cancer Institute (WIA)4 papers (2018–2023)David S. Hong · The University of Texas MD Anderson Cancer Center3 papers (2019–2022)Charles D. Blanke · SWOG Cancer Research Network3 papers (2018–2024)Hansi Zhang · Jilin University3 papers (2019–2020)Theodore S. Hong · Harvard University3 papers (2021–2025)Peter C. Lucas · Mayo Clinic3 papers (2018–2024)Marc J. Gollub · MACOM (United States)3 papers (2021–2023)Sandip Pravin Patel · Hindu College of Pharmacy3 papers (2018–2024)Eileen M. O’Reilly · Erasmus MC Cancer Institute3 papers (2023–2025)Deborah Schrag · Worldwide Clinical Trials (United States)3 papers (2023–2025)